19-54337143-C-T

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2

The NM_012276.5(LILRA4):​c.953G>A​(p.Gly318Glu) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000932 in 1,609,784 control chromosomes in the GnomAD database, with no homozygous occurrence. 14/21 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000033 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000069 ( 0 hom. )

Consequence

LILRA4
NM_012276.5 missense, splice_region

Scores

1
2
13
Splicing: ADA: 0.1793
2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.618
Variant links:
Genes affected
LILRA4 (HGNC:15503): (leukocyte immunoglobulin like receptor A4) This gene encodes an immunoglobulin-like cell surface protein that is expressed predominantly on plasmacytoid dendritic cells (PDCs) and modulates the function of these cells in the immune response. Expression of this gene is downregulated by interleukin 3 (IL3). This gene is one of a cluster of highly related genes located at chromosomal region 19q13.4. [provided by RefSeq, Jan 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LILRA4NM_012276.5 linkc.953G>A p.Gly318Glu missense_variant, splice_region_variant Exon 6 of 8 ENST00000291759.5 NP_036408.4 P59901-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LILRA4ENST00000291759.5 linkc.953G>A p.Gly318Glu missense_variant, splice_region_variant Exon 6 of 8 2 NM_012276.5 ENSP00000291759.4 P59901-1
LILRA4ENST00000595581.1 linkn.50G>A splice_region_variant, non_coding_transcript_exon_variant Exon 2 of 2 3 ENSP00000471722.1 A0A075B7A5
ENSG00000275210ENST00000616950.1 linkn.26G>A non_coding_transcript_exon_variant Exon 1 of 8 3

Frequencies

GnomAD3 genomes
AF:
0.0000329
AC:
5
AN:
151970
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000328
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.00000807
AC:
2
AN:
247906
Hom.:
0
AF XY:
0.00000746
AC XY:
1
AN XY:
134000
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000291
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000332
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000686
AC:
10
AN:
1457814
Hom.:
0
Cov.:
39
AF XY:
0.00000414
AC XY:
3
AN XY:
724752
show subpopulations
Gnomad4 AFR exome
AF:
0.0000299
Gnomad4 AMR exome
AF:
0.000112
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000233
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
9.01e-7
Gnomad4 OTH exome
AF:
0.0000166
GnomAD4 genome
AF:
0.0000329
AC:
5
AN:
151970
Hom.:
0
Cov.:
32
AF XY:
0.0000269
AC XY:
2
AN XY:
74220
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.000328
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000680
ExAC
AF:
0.0000165
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jan 03, 2024
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.953G>A (p.G318E) alteration is located in exon 6 (coding exon 6) of the LILRA4 gene. This alteration results from a G to A substitution at nucleotide position 953, causing the glycine (G) at amino acid position 318 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.30
BayesDel_addAF
Benign
-0.27
T
BayesDel_noAF
Benign
-0.53
CADD
Benign
16
DANN
Benign
0.95
Eigen
Benign
-0.24
Eigen_PC
Benign
-0.48
FATHMM_MKL
Benign
0.055
N
M_CAP
Benign
0.0030
T
MetaRNN
Uncertain
0.46
T
MetaSVM
Benign
-1.0
T
PrimateAI
Benign
0.29
T
PROVEAN
Pathogenic
-6.9
D
REVEL
Benign
0.088
Sift
Benign
0.055
T
Sift4G
Uncertain
0.039
D
Vest4
0.18
MutPred
0.71
Loss of catalytic residue at A317 (P = 0.0236);
MVP
0.18
MPC
0.19
ClinPred
0.34
T
GERP RS
2.7
gMVP
0.42

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.18
dbscSNV1_RF
Benign
0.35
SpliceAI score (max)
0.10
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs773279262; hg19: chr19-54848414; COSMIC: COSV99393171; COSMIC: COSV99393171; API